GSK and CureVac form mRNA tech collaboration
GSK to make equity investment of £130m in CureVac as part of the deal
20th July 2020
Latest news
Synairgen's SNG001 shows strong promise in COVID-19 trial
The drug significantly cut the risk of developing severe disease and patients were twice as likely to recover versus placebo
20th July 2020
Gov signs deals with BioNTech/Pfizer and Valneva for COVID vaccines
The UK has now secured early access to three different types of promising COVID-19 vaccine candidates
20th July 2020
AZ' Farxiga fast-tracked for heart failure following MI
The move is based on the first indication-seeking registry-based randomised controlled trial
17th July 2020
UK animal research dips 3.4% in 2019
Animal testing has dipped to its lowest figure since 2007, but Animal Free Research UK has condemned the results as 'yet another wasted opportunity'
17th July 2020
NICE backing for Astella's Xospata
The drug is considered a cost-effective treatment for relapsed or refractory FLT3 mutation-positive acute myeloid leukaemia
17th July 2020
PM to announce extra £3bn for NHS
The funds are to help the health service prepare for a winter wave of coronavirus
17th July 2020
CR UK announces job cuts
The charity said it is having to streamline operations – including job cuts and halting certain programmes of work – as funding is decimated by the coronavirus pandemic
16th July 2020
US committee backs terlipressin approval for HRS-1
HRS-1 is an acute and life-threatening syndrome with a survival time of just two weeks if left untreated
16th July 2020
AZ unveils detailed data from THALES trial
The results show a 17% cut in the risk of subsequent stroke in patients taking Brilinta and aspirin
16th July 2020
UK's MHRA allows early access to lumasiran for ultra-rare disease
Lumasiran targets primary hyperoxaluria type 1 (PH1), which affects just around 90 people in the UK and one to three individuals per million in Europe
16th July 2020
Janssen's Tremfya wins psoriatic arthritis approval
The drug is the first IL-23 inhibitor approved for the condition
15th July 2020
Radiotherapy in fewer doses safe for early breast cancer
10-year study shows lower total dose of radiotherapy delivered in fewer but larger doses is safe
15th July 2020
FDA committee backs GSK's multiple myeloma drug
If approved, belantamab mafodotin will be a first-in-class anti-BCMA therapy for relapsed/refractory multiple myeloma
15th July 2020
Study indicates lockdown significantly reduced coronavirus
The findings provide a baseline for further research into how the virus is spreading in England
15th July 2020
